1 of 1
Story summary
- The genomics market is evolving due to advancements in sequencing technologies and personalized medicine.
- North America holds 42% market share, driven by substantial investments in genomic research.
- AI integration improves drug development and disease diagnosis, while population genomics initiatives tackle research representation disparities.
- Next-generation sequencing leads the market, particularly in oncology applications.
- Challenges include data management, variant interpretation, and a shortage of trained professionals.
